复发瘤良性变的发生有助于患者获得长期缓解(P<0.05)。
The occurrence of benign change might make the patient gain the long time remission (P < 0. 05).
接受certolizumab治疗的患者报告的严重副作用包括肺结核(包括潜伏期疾病复发)和恶性疾病,比如淋巴瘤。
Serious adverse events reported in certolizumab-treated patients included tuberculosis (including reactivation of latent disease) and malignant diseases such as lymphoma.
中文摘要目的:分析和探讨骨巨细胞瘤术后复发的相关因素。
ABSTRACT Objective: to study the factor affecting the recurrence of giant cell tumor of bone.
应用推荐